The Stem Cell Network (SCN)is a Canadian not-for-profit that supports stem cell and regenerative medicine research; training the next generation of highly qualified personnel; and knowledge mobilization and transfer of stem cell and regenerative medicine research. From the lab to the clinic, SCN’s goal is to power life-saving therapies and technologies through regenerative medicine research for the benefit of all. Created in 2001, with support from the Government of Canada, the Network has grown from a few dozen labs to more than 270 world-class research groups, supporting over 250 research projects and 30 clinical trials. Since its inception, over 25 biotech companies have been catalyzed or enhanced and more than 7,000 highly qualified personnel have been trained. In 2021, the Government of Canada demonstrated its continuing trust and support in SCN with an investment of $45 million for the 2022–2025 period. In 2023, the Government of Canada announced additional funding for SCN through the Strategic Science Fund that will support SCN to the end of the decade.
Looking for a particular Stem Cell Network employee's phone or email?
The Stem Cell Network annual revenue was $23 million in 2026.
Cate Murray is the President and CEO of Stem Cell Network.
14 people are employed at Stem Cell Network.
Stem Cell Network is based in Ottawa, Ontario.
The NAICS codes for Stem Cell Network are [5417, 541, 54, 54171, 541713].
The SIC codes for Stem Cell Network are [87, 873].